Chicago, IL -- (SBWIRE) -- 01/28/2014 -- PennyPicks.net prowls the markets, sifts through hundreds of companies and picks those positioned to move and then presents them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.Let’s have a look at today’s hot stocks: Plandai Biotechnology Inc (OTCMKTS:PLPL), InfoSonics Corporation (NASDAQ:IFON), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), SandRidge Energy Inc. (NYSE:SD)
Plandai Biotechnology Inc (OTCMKTS:PLPL) opened the session at $0.69, trading in a range of $0.67 - $0.93, and closed at $0.860. The stock showed a positive performance of +38.93% in the last trading session. The stock traded on a volume of 3.10 million shares and the average volume of the stock remained 335,195 shares. Plandai Biotechnology, Inc., formerly Diamond Ranch Foods, Ltd., through its subsidiaries focuses on the farming of whole fruits, vegetables and live plant material and the production of functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa.
Will PLPL Continue To Move Higher? Find Out Here
InfoSonics Corporation (NASDAQ:IFON) traded 2.89 million shares in the last business day while the average volume of the stock remained 646,420 shares. The stock showed a positive movement of +41.75% to end at $2.92. The 52 week range of the stock remained $0.38 - $3.08. InfoSonics Corporation is a provider of wireless handsets and accessories to carriers, distributors and original equipment manufacturers (OEMs) in Latin America, Asia Pacific, Europe and Africa. The Company designs, develop, source and sells its line of products under the verykool brand.
For How Long IFON will fight for Profitability? Read This Trend Analysis report
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported 7.90 million shares were exchanged during the last trade, while the average volume is about 5.79 million shares. The stock dropped -5.33% and finished the day at $6.93. The beta of the stock is recorded at -0.40. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
SandRidge Energy Inc. (NYSE:SD) the stock decreased -3.02% and finished the session at $6.11. Traded with volume of 8.93 million shares in the prior session and the average volume of the stock remained 11.01 million shares. SandRidge Energy, Inc. is an independent oil and natural gas company. The Company is engaged in development and production activities in the Mid-Continent, Gulf of Mexico and Permian Basin in west Texas. Its primary area of focus is the Mississippian formation, a shallow hydrocarbon system in the Mid-Continent area of northern Oklahoma and Kansas.
Will SD Get Buyers Even After The Recent Rally? Find Out Here
Our approach to penny stocks is completely different from most other sites out there. We prowl the markets, sift through hundreds of companies and pick those poised to move and then present them to you. Stocks with the greatest possibility of gains, period. We call it as we see it and we are real about it.
Please fully understand this disclaimer before using our site or joining our email list. If you have any questions please contact us at email@example.com
PennyPicks.net is a private membership service that specializes in providing opinions, comments and information on stocks to individuals who wish to receive them. Our reports are for information and entertainment purposes only and are distributed free of charge exclusively to individuals who wish to receive them.
Read More at: http://www.pennypicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)